Litigation Details for Recro Gainesville LLC v. Actavis Laboratories FL, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Recro Gainesville LLC v. Actavis Laboratories FL, Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-10-30 |
| Court | District Court, D. Delaware | Date Terminated | 2018-01-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Parties | RECRO GAINESVILLE LLC | ||
| Patents | 6,228,398; 6,902,742; 9,132,096; 9,713,611 | ||
| Attorneys | Megan Elizabeth Dellinger | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Recro Gainesville LLC v. Actavis Laboratories FL, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Recro Gainesville LLC v. Actavis Laboratories FL, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-10-30 | 1 | PageID #: 5 Patent Nos. 6,228,398 (the “’398 Patent); 6,902,742 (the “’742 Patent”); and 9,132,096…United States Patent No. 9,713,611 (“the ’611 Patent”). This action is based upon the Patent Laws of the…’611 Patent is a continuation of the ’096 Patent. The ’611 and ’096 Patents expire on the same day. …constitutes infringement of the ’398 Patent; the ’742 Patent; and the ’096 Patent. Those actions, filed on September…infringement of the grandparent patent of the presently asserted ’611 Patent. Recro I and this case are | External link to document | |
| 2017-10-30 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,713,611 B2. (fms) (Entered:…2017 29 January 2018 1:17-cv-01535 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
